"Natural Ozempic" and "supplements that increase GLP-1" reflect consumer interest in dietary and lifestyle approaches to the same pathways targeted by FDA-approved GLP-1 receptor agonists. This article covers what the evidence supports, what it does not, and the genetic variables that sit underneath every intervention — pharmacological or natural.